About Contact Us Careers

Bioabsorbable Stents Market Share

Request Free Sample Copy

Report ID: 3612
Published Date: Sep 19, 2024
Report Format: PDF, PPT

Buy Now

Bioabsorbable Stents Market Share

The bioabsorbable stents market in the region is further segmented by countries into Germany, UK, France, Italy, Spain, Russia, Netherlands, and the Rest of Europe. Out of these, the market in Germany is expected to generate the largest revenue of USD 42.2 Million by the end of 2030, up from a revenue of USD 21.0 Million in the year 2020. On the other hand, the market in North America is anticipated to generate the second-largest revenue by the end of 2030, and also grow with the highest CAGR of 8.66% during the forecast period.

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Bioabsorbable Stents Market Size & Share, Growth Trends 2036

Author Credits: Radhika Pawar

Report ID: 3612
Published Date: Sep 19, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing prevalence of cardiovascular diseases (cvds) and the rising focus of the government of nations to facilitate advance healthcare infrastructure are some of the major factors anticipated to drive the market growth.

The market is anticipated to attain a CAGR of 7.67% over the forecast period, i.e., 2021 â€“ 2030.

The lack of skilled professionals for using stents and the availability of low-cost alternatives are estimated to hamper the market growth.

The market in Europe region is anticipated to garner the largest revenue of USD 252.3 Million by the end of 2030 and display significant business opportunities for market growth.

The major players in the market are Abbott, Elixir Medical Corporation, BIOTRONIK SE & Co KG, Arterius Limited, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.

Inquiry Before Buying Request Free Sample